Article
Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors
25 Nov 2021
Abstract excerpt
Abstract Despite their limitations, unfractionated heparin (UFH) and bivalirudin remain standard-of-care parenteral anticoagulants for percutaneous coronary intervention (PCI). We discovered novel direct thrombin inhibitors (DTIs) from tick salivary transcriptomes and optimised their pharmacologic activity. The most potent, ultravariegin, inhibits thrombin with a K i of 4.0 pM, 445-fold better than bivalirudin....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
